{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:19Z","timestamp":1786119379643,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/jcp.0b013e318192e05c","type":"journal-article","created":{"date-parts":[[2009,1,7]],"date-time":"2009-01-07T03:13:44Z","timestamp":1231298024000},"page":"97-99","source":"Crossref","is-referenced-by-count":4,"title":["Trazodone Hypnotic Effect and Nocturnal Melatonin Secretion"],"prefix":"10.1097","volume":"29","author":[{"given":"Armando L.","family":"Morera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Abreu-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Garcia-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210128","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1345\/aph.19101","article-title":"Increased rate of trazodone prescribing with bupropion and selective serotonin-reuptake inhibitors versus tricyclic antidepressants.","volume":"34","author":"Clark","year":"2000","journal-title":"Ann Pharmacother"},{"key":"R2-27-20210128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4088\/JCP.v66n0409","article-title":"A review of the evidence for the efficacy and safety of trazodone in insomnia.","volume":"66","author":"Mendelson","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R3-27-20210128","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/pds.1385","article-title":"Reasons for antidepressant prescriptions in Canada.","volume":"16","author":"Patten","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R4-27-20210128","first-page":"109","article-title":"Melatonin administration and nocturnal sleep in insomniacs.","volume":"16","author":"Mendelson","year":"1987","journal-title":"Sleep Res"},{"key":"R5-27-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002280050729","article-title":"Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.","volume":"56","author":"Von Bahr","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"R6-27-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3940(94)91059-6","article-title":"Posture influences melatonin concentrations in plasma and saliva in humans.","volume":"167","author":"Deacon","year":"1994","journal-title":"Neurosci Lett"},{"key":"R7-27-20210128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1600-079X.2006.00365.x","article-title":"Seasonality of psychopathology and circannual melatonin rhythm.","volume":"41","author":"Morera","year":"2006","journal-title":"J Pineal Res"},{"key":"R9-27-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00004714-200104000-00008","article-title":"Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin.","volume":"21","author":"Hartter","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R10-27-20210128","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s002280000245","article-title":"Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes.","volume":"56","author":"Facciola","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"R11-27-20210128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00520-006-0111-0","article-title":"Does trazodone have a role in palliating symptoms?","volume":"15","author":"Davis","year":"2007","journal-title":"Support Care Cancer"},{"key":"R12-27-20210128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S1461145799001303","article-title":"Pharmacokinetics of trazodone and its major metabolite m-chlorophenylpiperazine in plasma and brain of rats.","volume":"2","author":"DeVane","year":"1999","journal-title":"Int J Neuropsychopharmacol"},{"key":"R13-27-20210128","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0022-3565(24)38897-4","article-title":"Serotonergic modulation of rat pineal gland activity: in vivo evidence for a 5-hydroxytryptamine(2C) receptor involvement.","volume":"295","author":"Steardo","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R14-27-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00733786","article-title":"Cellular and molecular mechanisms controlling melatonin release by mammalian pineal glands.","volume":"7","author":"Cardinali","year":"1987","journal-title":"Cell Mol Neurobiol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200902000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:09:27Z","timestamp":1786039767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200902000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318192e05c","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}